Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages
Open Access
- 1 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (4) , 511-517
- https://doi.org/10.1093/jac/dki059
Abstract
Objectives: Quinolones accumulate in eukaryotic cells and show activity against a large array of intracellular organisms, but systematic studies aimed at examining their pharmacodynamic profile against intracellular bacteria are scarce. The present work aims at comparing intracellular-to-extracellular activities in this context. Methods: We assessed the activities of ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin against the extracellular (broth) and intracellular (infected J774 macrophages) forms of Listeria monocytogenes (cytosolic infection) and Staphylococcus aureus (phagolysosomal infection) using a range of clinically meaningful extracellular concentrations (0.06–4 mg/L). Results: All four quinolones displayed concentration-dependent bactericidal activity against extracellular and intracellular L. monocytogenes and S. aureus for extracellular concentrations in the range 1–4-fold their MIC. Compared at equipotent extracellular concentrations, intracellular activities against L. monocytogenes were roughly equal to those that were extracellular, but were 50–100 times lower against S. aureus. Because quinolones accumulate in cells (ciprofloxacin, ∼3 times; levofloxacin, ∼5 times; garenoxacin, ∼10 times, moxifloxacin, ∼13 times), these data show that, intracellularly, quinolones are 5–10 times less potent against L. monocytogenes (P=0.065 [ANCOVA]), and at least 100 times less potent (P < 0.0001) against S. aureus. Because of their lower MICs and higher accumulation levels, garenoxacin and moxifloxacin were, however, more active than ciprofloxacin and levofloxacin when compared at similar extracellular concentrations. Conclusions: Quinolone activity is reduced intracellulary. This suggests that either only a fraction of cell-associated quinolones exert an antibacterial effect, or that intracellular activity is defeated by the local environment, or that intracellular bacteria only poorly respond to the action of quinolones.Keywords
This publication has 27 references indexed in Scilit:
- Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like TransporterAntimicrobial Agents and Chemotherapy, 2004
- Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2003
- Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage modelJournal of Antimicrobial Chemotherapy, 2003
- Clinical Role of Protein Binding of QuinolonesClinical Pharmacokinetics, 2002
- Location and Nature of the Surface Membrane Binding Site of Ciprofloxacin: A Fluorescence StudyLangmuir, 2001
- INTRACELLULAR PATHOGENS AND THE ACTIN CYTOSKELETONAnnual Review of Cell and Developmental Biology, 1998
- The Clinical Pharmacokinetics of LevofloxacinClinical Pharmacokinetics, 1997
- In Vitro Activity of Fluoroquinolones against Gram-Positive BacteriaDrugs, 1995
- Effect of Quinolones against Slowly Growing BacteriaChemotherapy, 1995
- Intracellular distribution and activity of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991